|
C4ORF42 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16740000000171E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.027810E-04 |
| Normal-vs-Stage2 |
2.889900E-02 |
| Normal-vs-Stage3 |
2.937900E-02 |
| Normal-vs-Stage4 |
1.443010E-01 |
| Stage1-vs-Stage2 |
7.311000E-01 |
| Stage1-vs-Stage3 |
8.189200E-01 |
| Stage1-vs-Stage4 |
7.135800E-01 |
| Stage2-vs-Stage3 |
9.131600E-01 |
| Stage2-vs-Stage4 |
9.259600E-01 |
| Stage3-vs-Stage4 |
8.612400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.47240000040128E-07 |
| Normal-vs-AfricanAmerican |
9.389800E-04 |
| Normal-vs-Asian |
8.180600E-01 |
| Caucasian-vs-AfricanAmerican |
7.497800E-01 |
| Caucasian-vs-Asian |
3.162400E-01 |
| AfricanAmerican-vs-Asian |
3.296200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.40560000048285E-07 |
| Normal-vs-Female |
1.171960E-04 |
| Male-vs-Female |
5.328600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.238500E-03 |
| Normal-vs-Extreme_Weight |
4.123300E-03 |
| Normal-vs-Obese |
1.53432999999703E-05 |
| Normal-vs-Extreme_Obese |
1.757200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.652200E-01 |
| Normal_Weight-vs-Obese |
1.146030E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.563800E-01 |
| Extreme_Weight-vs-Obese |
4.583600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.434000E-01 |
| Obese-vs-Extreme_Obese |
2.431000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.915840E-02 |
| Normal-vs-Age(41-60Yrs) |
3.0578000020931E-08 |
| Normal-vs-Age(61-80Yrs) |
1.139320E-03 |
| Normal-vs-Age(81-100Yrs) |
2.811200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.047400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.216600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.548400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.928020E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.841640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.564600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.75529999821589E-08 |
| Normal-VS-Type2 PRCC |
1.196090E-02 |
| Normal-VS-KIRP CIMP |
8.118600E-01 |
| Normal-VS-Unclassified PRCC |
8.563900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.003780E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.980400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.273800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.765400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.002180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.403900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.482040E-01 |
| Normal-vs-N1 |
3.602100E-02 |
| Normal-vs-N2 |
4.055400E-01 |
| N0-vs-N1 |
1.521410E-01 |
| N0-vs-N2 |
3.788200E-01 |
| N1-vs-N2 |
9.322000E-01 |
|
|
